TNF and colitis: Vedolizumab therapy in ICI-induced steroid-refractory colitis or non-responders to anti–TNF-α (60, 61);Early introduction (within 10 days of the onset) of VDZ and sustained 3 or more infusions (62).Available for tuberculosis patients.